Safety of switching to Migalastat from enzyme replacement therapy in Fabry disease: Experience from the Phase 3 ATTRACT study

Research output: Contribution to journalJournal articleResearchpeer-review

Derralynn A Hughes, Kathleen Nicholls, Gere Sunder-Plassmann, Ana Jovanovic, Ulla Feldt-Rasmussen, Raphael Schiffmann, Robert Giugliani, Vipul Jain, Chris Viereck, Jeffrey P Castelli, Nina Skuban, Jay A Barth, Daniel G Bichet

Original languageEnglish
JournalAmerican Journal of Medical Genetics. Part A
Issue number6
Pages (from-to)1069-1073
Number of pages5
Publication statusPublished - 2019

Number of downloads are based on statistics from Google Scholar and

No data available

ID: 224702411